These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 21328016)

  • 1. The functional sequelae of schizophrenia: consequences of long-term pharmacotherapy and the neurobiology of addiction.
    Falkai P; Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 2011 Mar; 261(2):83-4. PubMed ID: 21328016
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypofrontality in schizophrenia.
    Jones BD
    Can J Psychiatry; 1988 Apr; 33(3):243-5. PubMed ID: 2898284
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuroleptic dysphoria may be the missing link between schizophrenia and substance abuse.
    Voruganti LN; Heslegrave RJ; Awad AG
    J Nerv Ment Dis; 1997 Jul; 185(7):463-5. PubMed ID: 9240366
    [No Abstract]   [Full Text] [Related]  

  • 4. Can antipsychotic treatment contribute to drug addiction in schizophrenia?
    Samaha AN
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jul; 52():9-16. PubMed ID: 23793001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality in patients with schizophrenia.
    Dervaux A; Laqueille X
    Lancet; 2009 Nov; 374(9701):1592; author reply 1592-3. PubMed ID: 19897120
    [No Abstract]   [Full Text] [Related]  

  • 6. [Quetiapine and the potential for abuse].
    Aa E; Helland A; Spigset O
    Tidsskr Nor Laegeforen; 2012 Aug; 132(14):1619-20. PubMed ID: 22875127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diphenhydramine dependence: a need for awareness.
    de Nesnera AP
    J Clin Psychiatry; 1996 Mar; 57(3):136-7. PubMed ID: 8617701
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacological treatment of schizophrenia and co-occurring substance use disorders.
    Smelson DA; Dixon L; Craig T; Remolina S; Batki SL; Niv N; Owen R
    CNS Drugs; 2008; 22(11):903-16. PubMed ID: 18840032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Misuse and abuse of quetiapine].
    Piróg-Balcerzak A; Habrat B; Mierzejewski P
    Psychiatr Pol; 2015; 49(1):81-93. PubMed ID: 25844412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neurobiology in the neuropharmacology of antipsychotic drugs].
    Tassin JP
    Encephale; 2006 Jan; 32 Pt 2():S6-7. PubMed ID: 16800077
    [No Abstract]   [Full Text] [Related]  

  • 11. New perspectives on the neurobiology of schizophrenia and the role of atypical antipsychotics: introduction.
    Nemeroff CB
    Biol Psychiatry; 2001 Dec; 50(11):823-4. PubMed ID: 11743938
    [No Abstract]   [Full Text] [Related]  

  • 12. Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia.
    Konradi C; Heckers S
    Biol Psychiatry; 2001 Nov; 50(10):729-42. PubMed ID: 11720691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive disturbances in neuroleptic therapy.
    Strauss WH; Klieser E
    Acta Psychiatr Scand Suppl; 1990; 358():56-7. PubMed ID: 1978491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is it time to consider comorbid substance abuse as a new indication for antipsychotic drug development?
    Awad AG
    J Psychopharmacol; 2012 Jul; 26(7):953-7. PubMed ID: 22170735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrating the neurobiology of schizophrenia. Preface.
    Abi-Dargham A; Guillin O
    Int Rev Neurobiol; 2007; 78():xiii-xvi. PubMed ID: 17349855
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term Administration of Antipsychotic Drugs in Schizophrenia and Influence of Substance and Drug Abuse on the Disease Outcome.
    Werner FM; Covenas R
    Curr Drug Abuse Rev; 2017; 10(1):19-24. PubMed ID: 29065847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Akinesia, tardive dysmentia, and frontal lobe disorder in schizophrenia.
    Goldberg E
    Schizophr Bull; 1985; 11(2):255-63. PubMed ID: 2861656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity correlates with fewer symptoms in schizophrenia treated with long-term clozapine: gender difference.
    Hui L; Ye M; Tang W; Zhang F; Liu J; Liu L; Chen Y; Chen DC; Tan YL; Yang FD; Zhang XY
    Psychiatry Res; 2015 Feb; 225(3):741-2. PubMed ID: 25595339
    [No Abstract]   [Full Text] [Related]  

  • 19. Subjective tolerability of antipsychotic medications and the emerging science of subjective tolerability disorders.
    Awad AG
    Expert Rev Pharmacoecon Outcomes Res; 2010 Feb; 10(1):1-4. PubMed ID: 20121558
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia.
    Horacek J; Bubenikova-Valesova V; Kopecek M; Palenicek T; Dockery C; Mohr P; Höschl C
    CNS Drugs; 2006; 20(5):389-409. PubMed ID: 16696579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.